Genascence

Developer of gene therapies for musculoskeletal and joint diseases

placePalo Alto, California, United States calendar_todayFounded 2017 groups6 employees language genascence.com

Innovation

2 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 92 times.

YearFilings
20201
20211
20221
20241
20252
20261

Social engagement

Social engagement: 874 social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Polymerase Capital, DeepWork Capital, University of Florida.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

30 Sep 2025
Event
ESGCT25
Coming soon